ArticlePloS one2025
Development and validation of a clinical prediction model for in-hospital heart failure risk following PCI in patients with coronary artery disease.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePatients with acute coronary syndrome (ACS) are at increased risk of in-hospital heart failure (HF) following percutaneous coronary intervention (PCI), yet understanding of the associated risk factors is limited. This study aims to identify predictors of in-hospital HF after PCI and to develop and validate a clinical prediction model for the early identification of high-risk patients.
methodsWe retrospectively analyzed data from the patients hospitalized for ACS who underwent PCI at Henan Provincial Hospital of Traditional Chinese Medicine from 01/01/2019-01/10/2023. Patients were classified into non-HF and HF groups based on the occurrence of heart failure after PCI. LASSO regression and logistic regression were employed to identify potential predictors. The model's diagnostic efficacy was assessed using receiver operating characteristic curves and calibration curves, while decision curve analysis and clinical impact curve were utilized to evaluate clinical benefits.
resultsA total of 309 patients were included in this study, of whom 79.93% were male, with a mean age of 57.84. Key predictors included New York Heart Association (NYHA) classification, smoking status, right coronary artery occlusion after PCI, left ejection fraction (LVEF), and N-terminal fragment of brain natriuretic peptides. The area under the curve (AUC) was 0.910 (95% CI: 0.868-0.953), indicating strong predictive ability. Decision curve analysis and clinical impact curve demonstrated good clinical applicability of the nomogram.
conclusionThe identified predictors and the prediction model can be used in identifying high-risk individuals who develop HF hospital admission after PCI, or as a basis for further guiding personalized prevention and treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.